Hyperhomocysteinemia and pregnancy - Review of our present understanding and therapeutic implications

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 93, Issue 2, 2000, Pages 157-165

  Aubard, Yves ^a   Darodes, Nicole ^b   Cantaloube, Muriel ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

Homocysteine; Hyperhomocysteinemia; Methionine; Pre eclamp sia; Pregnancy

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTICOAGULANT AGENT; CYANOCOBALAMIN; CYSTATHIONINE BETA SYNTHASE; FOLIC ACID; HEPARIN CALCIUM; HOMOCYSTEINE; LOW MOLECULAR WEIGHT HEPARIN; METHIONINE; METHIONINE SYNTHASE; PYRIDOXINE; TETRAHYDROFOLIC ACID; UNCLASSIFIED DRUG; VITAMIN B GROUP; VITAMIN B9;

ANTICOAGULANT THERAPY; ARTICLE; DISEASE COURSE; FETUS DEATH; HUMAN; HYPERCOAGULABILITY; HYPERHOMOCYSTEINEMIA; INTRAUTERINE GROWTH RETARDATION; NEURAL TUBE DEFECT; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; THROMBOEMBOLISM; TREATMENT PLANNING; VITAMIN SUPPLEMENTATION;

EID: 0033764843     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(00)00282-7     Document Type: Article

References (72)

1. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arterosclerosis
2. The pathogenesis of coronary artery disease. A possible role for methionine metabolism
3. Enzyme conversion immunoassay for determining total homocysteine in plasma or serum
4. Total homocysteine in plasma or serum: Methods and clinical applications
5. Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction
6. Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia
7. Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies
8. Fasting or post-load homocysteine: Which should be measured in relation to vascular risk?
9. Homocysteine and cysteine: Determinants of plasma levels in middle-aged and elderly subjects
10. Protein-bound homocysteine. A possible risk factor for coronary artery disease
11. Hormone replacement therapy may reduce high serum homocysteine in post menopausal women
12. Changes in homocysteine levels during normal pregnancy
13. Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland
14. The natural history of homocystinuria due to cystathionine beta-synthetase deficiency
15. Intermediate homocysteinemia; a thermolabile variant of methylenetetrahydrofolate reductase
16. Clinical chemistry and molecular biology of homocysteine metabolism: An update
17. Improved identification of heterozygotes for homocystinuria due to cystathionine synthetatse deficiency by the combination of methionine loading and enzyme determination in cultured fibroblast
18. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease; the result of a meta-analysis
19. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: Implications for folate intake recommendations
20. Homocysteine and vascular disease
21. Hyperhomocysteinemia: An independent risk factor for vascular disease
22. Hyperhomocysteinemia. A common and easily reversible risk factor for occlusive atherosclerosis
23. Heterozygoty for homocystinuria in premature peripheral and cerebral occlusive arterial disease
24. Hyperhomocysteinemie chez les patients coronariens
25. Plasma homocystine levels in men with premature coronary artery disease
26. The case that hyperhomocysteinemia is the risk factor for coronary artery disease
27. Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis?
28. High prevalence of hyperhomocysteinemia in patients with juvenile venous thrombosis
29. Homocysteine in cerebral macroangiopathy and microangiopathy
30. Homocysteine et pathologie cardiovasculaire
31. Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type 1 diabetes mellitus
32. Plasma homocysteine concentrations in Japanese patients with non insulin-dependent diabetes mellitus: Effect of parenteral methylcobalamin treatment
33. Mechanism of thrombogenesis and accelerated atherogenesis in homocysteinemia
34. Hyperhomocystinemia is a risk factor for arterial endothelial dysfunction in humans
35. Pathogenesis of vascular disease in hyperhomocysteinaemia
36. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia. An effect reversible with vitamin C therapy
37. Circulating lipid hydroperoxide levels in human hyperhomocysteinemia. Relevance to development of arteriosclerosis
38. Activation of endogenous factor V by a homocysteine-induced vascular endothelial activator
39. Effects of age, lipoproteins and hemostatic parameters on the role of homocysteinemia as a cardiovascular risk factor in men
40. Homocysteine and hemostasis: Pathogenic mechanism predisposing to thrombosis
41. Vascular dysfunction in monkeys with diet-induced hyperhomocysteinemia
42. The relationship between maternal and neonatal umbilical cord plasma homocysteine suggests a potential role for maternal homocysteine in fetal metabolism
43. Maternal and fetal levels of methionine and homocysteine in early human pregnancy
44. Hyperhomocysteinemia: A risk factor in women with unexpected recurrent early pregnancy loss
45. Prevention of neural tube defects and toxicity of L-homocysteine in cultured postimplantation rat embryos
46. Homocysteine induces congenital defects of the heart and neural tube: Effect of folic acid
47. A woman with five consecutive fetal deaths: Case report and retrospective analysis of hyperhomocysteinemia prevalence in 100 consecutive women with recurrent miscarriages
48. Preeclampsia: An endothelial cell disorder
49. Is oxidative stress the link in the two-stage model of pre-eclampsia?
50. Underlying disorders associated with severe early onset preeeclampsia
51. Elevated homocysteine levels with preeclampsia
52. Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation
53. High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone
54. Hyperhomocysteinaemia: A risk factor for placental abruption or infarction
55. Open or closed? A world of difference: A history of homocysteine research
56. Homocysteine metabolism in pregnancies complicated by neural tube defects
57. Maternal hyperhomocysteinemia: A risk factor for neural-tube defects?
58. Intrauterine growth retardation, perinatal death, and maternal homocysteine levels
59. Periconceptional folic acid containing multivitamin supplementation
60. Inherited thrombophilic states
61. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
62. Inherited thrombophilia and pregnancy: The obstetric perspective
63. Disorders of transsulfuration
64. Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12
65. Effect of antioxidants on the occurrence of the pre-eclampsia in women at increased risk: A randomised trial
66. Assessment of homocysteine status
67. Plasma and red cell volumes during pregnancy
68. Homocysteine - A pathophysiological cornerstone in obstetrical and gynaecological disorders?
69. Methionine metabolism in mammals. Effect of age, diet, and hormones on three enzymes of the pathway in rat tissues
70. Cortisol and estradiol: Non genetic factors for hyperhomocystinemia
71. Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocysteinaemia in patients with premature arterial disease and their relatives
72. Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemia: A double-blind, randomised, factorial-design, controlled trial